NASDAQ: ACON
Aclarion Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ACON stock forecasts and price targets.

Forecast return on equity

Is ACON forecast to generate an efficient return?

Company
-44.76%
Industry
-1.64%
Market
56.32%
ACON's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACON forecast to generate an efficient return on assets?

Company
-42.87%
Industry
9.36%
ACON is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACON earnings per share forecast

What is ACON's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$14.10
Avg 2 year Forecast
-$12.13

ACON revenue forecast

What is ACON's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$110.0k+101.46%
Avg 2 year Forecast
$270.0k+394.5%
ACON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACON revenue growth forecast

How is ACON forecast to perform vs Health Information Services companies and vs the US market?

Company
101.46%
Industry
6.52%
Market
48.98%
ACON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACON vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
ACON$7.53N/AN/A
MNDR$1.07N/AN/A
OTRK$0.50N/AN/A
WORX$0.43N/AN/A
FOXO$0.18N/AN/A

Aclarion Stock Forecast FAQ

What is ACON's earnings growth forecast for 2025-2026?

(NASDAQ: ACON) Aclarion's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 26.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.73%.

Aclarion's earnings in 2025 is -$6,697,619.On average, 1 Wall Street analyst forecast ACON's earnings for 2025 to be -$8,211,431, with the lowest ACON earnings forecast at -$8,211,431, and the highest ACON earnings forecast at -$8,211,431.

In 2026, ACON is forecast to generate -$7,064,160 in earnings, with the lowest earnings forecast at -$7,064,160 and the highest earnings forecast at -$7,064,160.

If you're new to stock investing, here's how to buy Aclarion stock.

What is ACON's revenue growth forecast for 2025-2026?

(NASDAQ: ACON) Aclarion's forecast annual revenue growth rate of 101.46% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 6.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 48.98%.

Aclarion's revenue in 2025 is $54,601.On average, 1 Wall Street analysts forecast ACON's revenue for 2025 to be $64,061, with the lowest ACON revenue forecast at $64,061, and the highest ACON revenue forecast at $64,061.

In 2026, ACON is forecast to generate $157,240 in revenue, with the lowest revenue forecast at $157,240 and the highest revenue forecast at $157,240.

What is ACON's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ACON) forecast ROA is -42.87%, which is lower than the forecast US Health Information Services industry average of 9.36%.

What is ACON's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ACON) Aclarion's current Earnings Per Share (EPS) is -$4,323.57. On average, analysts forecast that ACON's EPS will be -$14.10 for 2025, with the lowest EPS forecast at -$14.10, and the highest EPS forecast at -$14.10. In 2026, ACON's EPS is forecast to hit -$12.13 (min: -$12.13, max: -$12.13).

What is ACON's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ACON) forecast ROE is -44.76%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.